Today’s Drug Discovery Process “How Do We Discover Drugs”

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

David M. Pollock Medical College of Georgia Discovery-Academia.
The Role of Drug Metabolism Studies in Optimizing Drug Candidates
International Research for Global Health NAEJA Pharmaceutical Inc. INTEGRATED MEDICINAL CHEMISTRY.
Challenges in new drug discovery in South Asia
1 Marine Technology Summit November 16, Discovering and Developing New Medicines from Marine Microbes Nereus Pharmaceuticals Ken Lloyd, Ph.D. Chief.
Younas Masih RN, Post RN BSc.N (Lecturer ) New Life College Of Nursing Karachi 11/7/20141Antimicrobial medications.
The antibiotic reality
Chapter 15 NATURE AND NURTURE. You Started as One Cell: Stem cells.
Nanotechnology in Drug Discovery- Development and Delivery
1 Course. 3 U nique options. Biomedical Science Discoveries, Diagnostics and Cures 1.
OMPI, Aprli 2005Athelas SA Copyright STARTUPS, IP AND ALL THAT SORT OF THINGS IP issues as seen from the limited perspective of a startup company active.
Stages of drug development
Drug Discovery and Development How are drugs discovered and developed?
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &
Faculty of Medical Sciences School of Biomedical Sciences Dr Edwin Williams Director of Studies
Chemical Control Methods
Marine Drug Development and Delivery Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM ,
What keeps us away from bacteria!.  Antibacterial: Chemicals which prevent the growth and multiplication of bacteria  Antibiotics: Chemicals produced.
Anti-mRNA Strategies What is the antisense oligonucleotides? - Synthetic genetic material. - Interacts with natural genetic material (DNA or RNA) prevent.
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case M I C R.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
1 Antimicrobial Drugs. 2 Antimicrobal Chemotherapy Terms.
How I became a scientist: - and how new medicines are developed Dr Rosa Gualano Honorary Research &Teaching Fellow Department of Pharmacology & Therapeutics.
Developing medicines for the future and why it is challenging Angela Milne.
MRC Technology an independent life science medical research charity Biotech & Money 2016 Mr Andrew Mercieca, Director of Finance
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Purpose of Clinical Trials Assess safety and efficacy of Experimental treatments New combinations of drugs New approaches to surgery or radiation therapies.
Today’s Drug Discovery Process “How Do We Discover Drugs” Dr. Vincent P. Gullo Drew University.
RISE Honors Seminar 2014 Ronald Doll RISE Dept. S-332 X 3168 Training – Synthetic Organic Chemist (Ph.D. Duke Univ.) - National Institute.
26th April 2016, BioTrinity - London
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
Nucorion Pharmaceuticals, Inc. Overview Ligand Non-Confidential Nucorion Pharmaceuticals, Inc.  Newly formed US-based biotech company, initially.
Moxifloxacin Development in TB Dr. Martin Springsklee VP, Therapeutic Area Head, Clinical Development Anti-Infectives Bayer HealthCare AG GATB Annual Stakeholder.
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
The Stages of a Clinical Trial
A Clinical Stage Drug Company Developing Polymolecular Therapeutics For The Oncology, Neurology And Orthopedic Markets Dr. Brent Reynolds, CEO
B1 Topic 3: Preventing and Treating Disease
Drug Discovery &Development
Chapter 20 Antimicrobial Medications
Antibiotics: From Discovery to Resistance
Targeting p53 for Oncology Drug Discovery
Can Drug Discovery Research be Done At An Undergraduate Institution?
SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))
High Throughput Screening for Tuberculosis at NCL
Antibiotic Stewardship in Pennsylvania
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Discovery and Development of Medicines
Gestora brasileiro focada exclusivamente na área da saúde.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
Premium Immunotherapies to drive HNC Therapeutics in Asia-Pacific Market: Ken Research.
Therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer a.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
Bacterial Evoluation and Antibiotic Resistance
A new antivirulence approach against pathogenic bacteria
Madam Therapeutics Next generation antibiotics to fight global anti-microbial resistance November 2017.
Innovation & the Pharmaceutical Research & Development Industry
Branko Stefanovic Biomedical Sciences
Chapter 20 Antibacterial Agents
PN-III-ID_PCE_ Contract: 179/2017
Michael S. Glickman, Charles L. Sawyers  Cell 
Drug Design and Drug Discovery
Volume 21, Issue 9, Pages (September 2014)
Biological Medicine By Benji Marks.
A Suppression Strategy for Antibiotic Discovery
Antibacterial Drug Discovery (ADD) at Leeds
Antimicrobials and Antimicrobial Resistance
Principles of Antimicrobial Therapy
Presentation transcript:

Today’s Drug Discovery Process “How Do We Discover Drugs” Dr. Vincent P. Gullo Drew University From the reading, what is the first step in the drug discovery process. Understand a disease, figure out what’s wrong pick a target to modulate to correct the disease What is a target?

Topics My background Research interests Drug discovery process Previous seminar topics Possible seminar topics

Background B.S. in Chemistry – City College of NY Ph.D. in Organic Chemistry – Columbia University Career in Drug Discovery Spent 8 years at Merck focusing on discovering new drugs for cardiovascular disease, antibiotics and animal health drugs from natural sources 20 years at Schering-Plough working on discovering drugs from natural and synthetic compound sources for a broad range of therapeutic areas 3 years at a small biotech company searching for drugs from natural sources for a broad range of therapeutic areas.

Research Interests Antibacterials Need to treat resistant microorganisms MRSA Carbapenem resistant enterobacteriaceae (CRE) Lack of major interest by large pharma companies until recently Can be done at Drew with undergraduates Microbiological assays (Demain) Synthetic chemistry and instrumentation available If we are successful, contacts with small company to follow up further

The Drug Discovery Process Timeline – 12 to15 years Cost – $1 to 1.6 billion Target Selection Target Validation Assay Development Hits & Leads & Screening Lead Optimization Clinical Trials Phase I, Phase II, Phase III Development New Drug Application Market & Phase IV

Search for a New Antibacterial Target selection and validation Inhibit growth of the bacteria - Numerous successes using this approach Microbial assay - agar diffusion assay

Screening and Hit/Lead Identification Test (screen) 250 compounds from Dr. Houlihan’s library of compounds prepared for anorexia and cocaine addiction 13 compounds discovered with similar structures Synthesizing analogs to improve potency, spectrum of activity and PK

Previous Research Topics The Antibiotic Crisis (What is the problem and how to address it) Drug Discovery Compound Sources: Natural or Synthetic Compounds Tuberculosis (difficulties in treating TB and what are potential solutions) Hepatitis C virus (Will we ever be able to have a complete viral response) Collateral Damage: Comparing Targeted Therapies to Non-Specific Chemotherapy in Cancer Induced Pleuripotent Stem cells and the Potential to Cure Type one Diabetes Cystic Fibrosis: Are We on the Pathway to a Cure How is Exploring Nature Helping Us to Fight Cancer?

Possible Research Reports Anything along the drug discovery pathway Types of assays Phenotypic vs. Targeted Natural products Role in today’s drug discovery process? Diseases with unmet medical need Diabetes Heart disease Cancer Antibacterials/antifungals/antivirals